Clinical Trial Update: SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715) [Phase 2]

View source ↗

Summary

A Phase 2 study of SCH 727965 in mantle cell lymphoma or B-cell chronic lymphocytic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Mantle Cell Lymphoma

Drugs mentioned

• SCH 727965

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Lymphoma, Mantle-Cell, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 2 | Status: TERMINATED